Embed this press release by copying the code below:
Rottenstein Law Group Notes Request for Physician Participation in Registry to Track Use of Risperdal and Other Atypical Antipsychotic Drugs by Pregnant Women
Rottenstein Law Group Notes Request for Physician Participation in Registry to Track Use of Risperdal and Other Atypical Antipsychotic Drugs by Pregnant Women